Sirius Pharmaceuticals Private Limited logo

Sirius Pharmaceuticals Private Limited

This company manufactures and sells pharmaceutical intermediates to various clients worldwide.
1991 | Mumbai, Maharashtra (India) | Active

Last Updated:

June 26, 2024
HomeCompanySirius Pharmaceuticals Private Limited

Who are the key members and board of directors at Sirius Pharmaceuticals?

Board Members(2)

NameDesignationAppointment DateStatus
Ajay Melwani In Director 09-Oct-1991Current
Ayush Melwani In Director 07-Sep-2018Current

Financial Performance of Sirius Pharmaceuticals.

Sirius Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 14.39% decrease. The company also saw a substantial fall in profitability, with a 15.65% decrease in profit. The company's net worth moved up by a moderate rise of 6.83%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-14.39%
Revenue from Operations
-9.78%
Total Assets
5.47%
Profit or Loss
-15.65%
Net Worth
6.83%
EBITDA
47.33%

Related Corporates (Common Directorship)

Charges (Loans)

Satisfied Charges

₹30.00 M

LenderAmountStatus

Hdfc Bank Limited

Creation Date: 09 Jan 2006
₹3.00 CrSatisfied

How Many Employees Work at Sirius Pharmaceuticals?

Unlock and access historical data on people associated with Sirius Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Sirius Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Sirius Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Sirius Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

    31 Mar 2023

  • Director Appointment

    Ayush Ajay Melwani was appointed as a Director was appointed as a Director on 07 Sep 2018 & has been associated with this company since 6 years 3 months .

    07 Sep 2018

  • Charges

    A charge registered on 09 Jan 2006 via Charge ID 80003644 with Hdfc Bank Limited was fully satisfied on 22 Mar 2016.

    22 Mar 2016

  • Charges

    A charge with Hdfc Bank Limited of Rs. 30.00 M registered on 09 Jan 2006 with Charge ID 80003644 was modified on 22 May 2006.

    22 May 2006

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 30.00 M with Charge ID 80003644 was registered on 09 Jan 2006.

    09 Jan 2006

Frequently asked questions

  • Sirius Pharmaceuticals Private Limited was incorporated on 09 Oct 1991.

  • The authorized share capital of Sirius Pharmaceuticals Private Limited is ₹ 5.00 M and paid-up capital is ₹ 0.50 M.

  • Currently 2 directors are associated with Sirius Pharmaceuticals Private Limited.

    • Ajay Amerlal Melwani
    • Ayush Ajay Melwani
  • As per Ministry of Corporate Affairs (Mca), the registered address of Sirius Pharmaceuticals Private Limited is 301 Sainara 21 North Avenue N. Linking Road, Junction Santacruz (W), Mumbai, Maharashtra, India, 400054.

  • The corporate identification number (CIN) of Sirius Pharmaceuticals Private Limited is U24239MH1991PTC063523 and the company number is 063523 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Sirius Pharmaceuticals Private Limited is https://www.siriuspharma.com

  • According to the financial reports for the fiscal year 2020, the revenue trend for Sirius Pharmaceuticals Private Limited has fallen by -14.39%.

  • The financial reports for the fiscal year 2020 indicates that The net worth of Sirius Pharmaceuticals Private Limited has experienced an upsurge of 6.83%.

  • The most recent Balance Sheet for Sirius Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development